Want to join the conversation?
$SRE expects to meet its 2016 adjusted EPS of $4.60-5.00 and to achieve about 12% compound annual adjusted EPS growth from 2016 through 2020. $SRE continues to add new projects both domestically and internationally that support long-term growth strategy, with addition of Mexican marine pipeline and acquisition of new wind farm in Michigan.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.